Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. [electronic resource]
Producer: 20111128Description: 1212-9 p. digitalISSN:- 1528-0012
- Adult
- Aged
- Antiviral Agents -- adverse effects
- Biomarkers -- blood
- Carcinoma, Hepatocellular -- surgery
- Chi-Square Distribution
- DNA, Viral -- blood
- Female
- Guanine -- adverse effects
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- complications
- Hong Kong
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kaplan-Meier Estimate
- Liver Cirrhosis -- surgery
- Liver Neoplasms -- surgery
- Liver Transplantation
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Postoperative Care
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.